Open questions in autoimmunity: Discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting

Carlo Selmi, Yehuda Shoenfeld

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The recent CORA (Controversies in Rheumatology and Autoimmunity) meeting held in 2013 represented a unique opportunity for rheumatologists to address several topics. Among these, four topics include: (i) the role of epigenetic changes in the pathogenesis of rheumatoid arthritis (RA), as shown by studies in monozygotic twins; (ii) the cardiovascular and atherosclerotic risk in patients with RA treated with biologics; (iii) the use of new biomarkers for the diagnosis and follow-up of RA and other autoimmune diseases, as represented by the new automatic machines for anti-nuclear antibodies detection, or ultrasound imaging to follow RA progression; and (iv) the latest guidelines on how to use and manage biologic therapies in RA and other autoimmune diseases, such as lupus. In summary, we will herein present these topics of discussion and underline the conclusions obtained by rheumatologists during the 2013 CORA Meeting.

Original languageEnglish (US)
Article number50
JournalBMC Medicine
Volume12
Issue number1
DOIs
StatePublished - Mar 18 2014

Fingerprint

Rheumatology
Autoimmunity
Rheumatoid Arthritis
Autoimmune Diseases
Biological Therapy
Monozygotic Twins
Biological Products
Epigenomics
Anti-Idiotypic Antibodies
Ultrasonography
Biomarkers
Guidelines
Rheumatologists

Keywords

  • Anti-nuclear antibodies
  • Atherosclerosis
  • Cardiovascular system
  • DNA methylation
  • microRNA
  • Rheumatoid arthritis
  • Ultrasonography

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Open questions in autoimmunity : Discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting. / Selmi, Carlo; Shoenfeld, Yehuda.

In: BMC Medicine, Vol. 12, No. 1, 50, 18.03.2014.

Research output: Contribution to journalArticle

@article{f53b39d36ab14334ad4850f734590ed9,
title = "Open questions in autoimmunity: Discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting",
abstract = "The recent CORA (Controversies in Rheumatology and Autoimmunity) meeting held in 2013 represented a unique opportunity for rheumatologists to address several topics. Among these, four topics include: (i) the role of epigenetic changes in the pathogenesis of rheumatoid arthritis (RA), as shown by studies in monozygotic twins; (ii) the cardiovascular and atherosclerotic risk in patients with RA treated with biologics; (iii) the use of new biomarkers for the diagnosis and follow-up of RA and other autoimmune diseases, as represented by the new automatic machines for anti-nuclear antibodies detection, or ultrasound imaging to follow RA progression; and (iv) the latest guidelines on how to use and manage biologic therapies in RA and other autoimmune diseases, such as lupus. In summary, we will herein present these topics of discussion and underline the conclusions obtained by rheumatologists during the 2013 CORA Meeting.",
keywords = "Anti-nuclear antibodies, Atherosclerosis, Cardiovascular system, DNA methylation, microRNA, Rheumatoid arthritis, Ultrasonography",
author = "Carlo Selmi and Yehuda Shoenfeld",
year = "2014",
month = "3",
day = "18",
doi = "10.1186/1741-7015-12-50",
language = "English (US)",
volume = "12",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Open questions in autoimmunity

T2 - Discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting

AU - Selmi, Carlo

AU - Shoenfeld, Yehuda

PY - 2014/3/18

Y1 - 2014/3/18

N2 - The recent CORA (Controversies in Rheumatology and Autoimmunity) meeting held in 2013 represented a unique opportunity for rheumatologists to address several topics. Among these, four topics include: (i) the role of epigenetic changes in the pathogenesis of rheumatoid arthritis (RA), as shown by studies in monozygotic twins; (ii) the cardiovascular and atherosclerotic risk in patients with RA treated with biologics; (iii) the use of new biomarkers for the diagnosis and follow-up of RA and other autoimmune diseases, as represented by the new automatic machines for anti-nuclear antibodies detection, or ultrasound imaging to follow RA progression; and (iv) the latest guidelines on how to use and manage biologic therapies in RA and other autoimmune diseases, such as lupus. In summary, we will herein present these topics of discussion and underline the conclusions obtained by rheumatologists during the 2013 CORA Meeting.

AB - The recent CORA (Controversies in Rheumatology and Autoimmunity) meeting held in 2013 represented a unique opportunity for rheumatologists to address several topics. Among these, four topics include: (i) the role of epigenetic changes in the pathogenesis of rheumatoid arthritis (RA), as shown by studies in monozygotic twins; (ii) the cardiovascular and atherosclerotic risk in patients with RA treated with biologics; (iii) the use of new biomarkers for the diagnosis and follow-up of RA and other autoimmune diseases, as represented by the new automatic machines for anti-nuclear antibodies detection, or ultrasound imaging to follow RA progression; and (iv) the latest guidelines on how to use and manage biologic therapies in RA and other autoimmune diseases, such as lupus. In summary, we will herein present these topics of discussion and underline the conclusions obtained by rheumatologists during the 2013 CORA Meeting.

KW - Anti-nuclear antibodies

KW - Atherosclerosis

KW - Cardiovascular system

KW - DNA methylation

KW - microRNA

KW - Rheumatoid arthritis

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=84899145717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899145717&partnerID=8YFLogxK

U2 - 10.1186/1741-7015-12-50

DO - 10.1186/1741-7015-12-50

M3 - Article

C2 - 24642104

AN - SCOPUS:84899145717

VL - 12

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

M1 - 50

ER -